ah5n6c
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 18, 2022 (NCT05422326)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05874713 | Phase 2 | Jun 7, 2023 | CSL Behring, Department of Health and Human Services |
| NCT05422326 | Phase 2 | Jul 18, 2022 | CSL Behring |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CSL Behring | For profit | 2 | 2 | 1 | 2022 |
| Department of Health and Human Services | Government | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1